5 Team Health Holdings Analyst Ratings, Earnings, Dividends and Insider Trades | $TMH | NYSE:TMH | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Team Health Holdings Company Profile (NYSE:TMH) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Team Health Holdings (NYSE:TMH) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 1 Hold Rating(s), 7 Buy Rating(s), 1 Strong Buy Rating(s)Consensus Rating:Buy (Score: 3.00)Consensus Price Target: $47.80 (3.13% upside) Analysts' Ratings History for Team Health Holdings (NYSE:TMH) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare12/17/2013KeyCorpInitiated CoverageHoldView 12/3/2013SunTrustInitiated CoverageBuy$54.00View 11/14/2013RBC CapitalBoost Price TargetSector Perform -> Outperform$43.00 -> $50.00View 11/7/2013Deutsche BankBoost Price Target$52.00 -> $53.00View 11/7/2013Stifel NicolausReiterated RatingBuy$44.00View 11/7/2013Feltl & Co.Boost Price TargetBuy$47.00 -> $55.00View 11/6/2013Credit SuisseBoost Price TargetOutperform$43.00 -> $50.00View 10/16/2013Stifel NicolausReiterated RatingBuy$43.00 -> $44.00View 10/9/2013Deutsche BankBoost Price TargetBuy$46.00 -> $52.00View 8/5/2013RBC CapitalBoost Price TargetOutperform$39.00 -> $43.00View 8/1/2013Stifel NicolausLower Price TargetBuy$46.00 -> $43.00View 7/15/2013Deutsche BankReiterated RatingBuy$43.00View 7/3/2013Deutsche BankBoost Price Target$40.00 -> $43.00View 6/24/2013Deutsche BankReiterated RatingBuy$40.00View 6/24/2013Stifel NicolausBoost Price TargetBuy$41.00 -> $46.00View 5/2/2013Stifel NicolausBoost Price TargetBuy$37.00 -> $41.00View 5/2/2013Piper JaffrayBoost Price TargetOverweight$40.00 -> $42.00View 5/2/2013Deutsche BankBoost Price TargetBuy$37.50 -> $40.00View 5/2/2013BarclaysBoost Price TargetOverweight$41.00 -> $42.00View 4/4/2013Goldman SachsUpgradeNeutral -> Conviction Buy$33.00 -> $43.00View 3/21/2013Credit SuisseBoost Price TargetOutperform$39.00 -> $43.00View 3/18/2013Johnson RiceBoost Price Target$43.00 -> $45.00View 2/8/2013Goldman SachsReiterated RatingNeutral$30.00 -> $33.00View 2/7/2013BarclaysBoost Price TargetOverweight$35.00 -> $41.00View 2/7/2013StephensUpgradeEqual Weight -> Overweight$30.00 -> $42.00View 2/7/2013Citigroup Inc.Boost Price TargetBuy$32.00 -> $42.00View 2/6/2013Stifel NicolausReiterated RatingBuy$35.00 -> $37.00View 1/14/2013Stifel NicolausBoost Price TargetBuy$30.00 -> $35.00View 1/4/2013BarclaysBoost Price TargetOverweight$33.00 -> $35.00View 11/2/2012RBC CapitalUpgradeSector Perform -> Outperform$28.00 -> $34.00View 11/2/2012StephensDowngradeOverweight -> Equal Weight$32.00 -> $30.00View 11/1/2012Stifel NicolausBoost Price Target$30.00View 10/31/2012Piper JaffrayUpgradeNeutral -> Overweight$27.00 -> $30.00View 9/6/2012Wells Fargo & Co.Initiated CoverageMarket PerformView 8/1/2012BarclaysReiterated RatingOverweightView 8/1/2012Bank of AmericaBoost Price Target$31.00 -> $32.00View 7/31/2012Deutsche BankBoost Price Target$29.00View 7/24/2012Stifel NicolausBoost Price Target$27.00View 6/5/2012Stifel NicolausInitiated CoverageBuy$26.00View 5/2/2012Deutsche BankBoost Price TargetBuy$25.00 -> $26.00View (Data available from 3/9/2012 forward) Earnings History for Team Health Holdings (NYSE:TMH)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/12/2014Q413$0.44$0.46$610.72 million$621.80 millionViewListenView 11/6/2013Q313$0.47$0.49$596.85 million$606.10 millionViewListenView 7/30/2013Q2 2013$0.45$0.44$585.91 million$579.70 millionViewListenView 4/30/2013Q1 2013$0.43$0.44$555.94 million$575.90 millionViewListenView 2/5/2013Q4 2012$0.36$0.39$535.15 million$544.80 millionViewListenView 10/31/2012Q312$0.40$0.44$522.37 million$539.20 millionViewN/AView 7/31/2012$0.40$0.39ViewN/AView 5/1/2012$0.30$0.37ViewN/AView 2/7/2012$0.29$0.31ViewN/AView 11/1/2011$0.30$0.30ViewN/AView 8/2/2011$0.33$0.33ViewN/AView 5/3/2011$0.29$0.33ViewN/AView 2/8/2011$0.22$0.25ViewN/AView (Data available from 1/1/2011 forward) Dividend History for Team Health Holdings (NYSE:TMH)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Team Health Holdings (NYSE:TMH)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare2/18/2014Greg RothCEOSell10,000$44.21$442,100.00View 1/15/2014Greg RothCEOSell10,000$47.14$471,400.00View 12/16/2013Greg RothCEOSell10,000$46.00$460,000.00View 11/15/2013Greg RothCEOSell10,000$45.59$455,900.00View 11/8/2013Glenn DavenportDirectorSell15,000$44.07$661,050.00View 10/18/2013David P JonesCFOSell20,000$44.26$885,200.00View 10/16/2013David P JonesCFOSell12,500$42.25$528,125.00View 10/15/2013Greg RothCEOSell10,000$41.10$411,000.00View 10/3/2013David JonesCFOSell35,553$40.25$1,431,008.25View 9/16/2013Greg RothCEOSell10,000$36.83$368,300.00View 8/16/2013Greg RothCEOSell11,242$39.75$446,869.50View 7/15/2013Greg RothCEOSell20,000$40.41$808,200.00View 12/31/2012Blackstone Management AssociatMajor ShareholderSell8,792,572$28.85$253,665,702.20View (Data available from 1/1/2013 forward) About Team Health Holdings Team Health Holdings, Inc. is a supplier of outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the United States, based upon revenues, patient visits, and number of clients. Team Health serves approximately 730 civilian and military hospitals, clinics and physician groups in 47states with a team of more than 7,100 affiliated healthcare professionals, including physicians, physician assistants, nurse practitioners, and nurses. In May 2012, it acquired the operations of The Exigence Group and its related entities. In August 2012, the Company announced the acquisition of the operations of Delphi Healthcare Partners and its related entities. In December 2012, the Company acquired practice of Mobile Emergency Group, PC (MEG), the physician group. In January 2013, the Company acquired the practice of San Francisco Physicians Internationale, Inc. Headlines: (2/11) Team Health Holdings, Inc. Announces Fourth Quarter and Fiscal 2013 Financial Results (2/26) Team Health To Present At Citi Global Conference; Webcast At 9:40 AM ET (2/26) Team Health To Present At RBC Healthcare Conference; Webcast At 3:35 PM ET (3/3) TeamHealth Expands West Virginia Presence (3/3) Press Release Industry, Sector and Symbol: Sector: Healthcare Industry: Health Care Providers & Services Sub-Industry: Health Care Services Exchange: NYSE Symbol: TMH CUSIP: 87817A10 Key Metrics: Previous Close: $46.0450 Day Moving Average: $44.6356200 Day Moving Average: $43.3851 P/E Ratio: 37.13P/E Growth: 1.26Market Cap: $3.246BCurrent Quarter EPS Consensus Estimate: $2.16 EPS Additional Links: View TMH on Google FinanceView TMH on Yahoo FinanceView TMH's Company Profile on ReutersSearch for Team Health Holdings Inc. on Google Team Health Holdings (NYSE:TMH) Chart for Sunday, March, 9, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.